Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Oaks JJ, Santhanam R, Walker CJ, Roof S, Harb JG, Ferenchak G, Eisfeld A K, Van Brocklyn JR, Briesewitz R, Saddoughi SA, et al. Blood. 2013 Aug 7. PMID: 23926298. Abstract CommentRecommendBookmarkWatch